Integrated Solutions For Advanced Therapies

Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. With therapies gaining approvals in additional countries, the promise of cell and gene therapy continues to expand as treatments for new diseases and some as earlier lines of treatment.

Drug developers face mounting challenges linked to rapid increases in demand for the complex modalities while also accounting for the need to drive process efficiencies at scale. Working with the right partner that offers integrated services can help ease the increasingly common problems with scale, access to high-demand raw material, viral vector production, and quality requirements.